0001 THICK FILM COMPOSITION

E.I.DuPont

Revision date : 2001-06-03

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

General Information

Revision date

2001-06-03

Product name

0001 THICK FILM COMPOSITION

Product name

0001 THICK FILM COMPOSITION

Identification on the label/Trade name

(800)441-7515

Product Synonyms

Ethyl Cellulose

CAS No.

112-73-2

Manufacturer Name

E.I.DuPont

Emergency telephone

(800)424-9300

Icons in SDS

Company Information

company name

E.I.DuPont

Section 2

Health hazards

INFORMATION PRINCIPAL HEALTH EFFECTS: >>eTerpineol (Mixed Isomers) ****Toxic effects described in animals include: BY SKIN OR EYE CONTACT: Skin irritation; Eye irritation; No skin sensitization. ****Additional animal tests have shown: BY INHALATION OF VAPORS OR FUMES FROM HEATED MATERIALS: No genetic damage in bacterial cell cultures; BY INGESTION: Developmental toxicity at dosage levels showing maternal toxicity. INFORMATION continuep) x**In addition: Du Pont considers epoxy resins to have weak carcinogenic potential. However, these resins will not present a significant carcinogenic hazard for humans if handled with proper industrial hygiene practices; There are inconclusive or unverified reports of human sensitization. >>>Niobium Compound >>>Silver (Metallic) *e*+*Toxic effects described in animals include: Liver damage. ***+*Additional animal tests have shown: Genetic damage in mammalian cell cultures; No genetic damage in bacterial cell cultures; No animal test reports are available to define carcinogenic, developmental, or reproductive hazards. INFORMATION(continueD) INFORMATION(contINUED) Units: ppm 0.3 (C) 0.75 0.5 (C) Also, DuPont has established and observes the following limits: Name/Units 12 hr shr 15min Ceiling BORIC ACID, total dust Units: mg/m3 5 SILICA, amorphous (DE, pptd@. and gel), respirable Units: mg/m3 3 SILICA, amorphous, (DE, pptd. and geil), total Units: mg/m3 6 FORMALDEHYDE Units: ppm z L 2 See Explanation Below For Addi- tional Exposure Recommendation LEAD and LEAD COMPOUNDS in Blood as Lead (Pb) DuPont considers Pb and its compounds to be PROBABLE HUMAN DEVELOPMENTAL TOXINS. A woman of childbearing potential should be warned of the risk to an unborn child in workplace operations that involve exposures to Pb and its compounds. An UNBORN CHILD MAY BE AT RISK OF PERM- ANENT INJURY from a pregnant woman’s exposure to Pb and its compounds under conditions where exposure would not be expected to cause adverse effects in an adult female. There is no clear evidence of association with congenital malformations. As a guide to protect the unborn child, a woman of childbearing capability who might elect to work with Pb or its compounds should avoid adding Pb to her normal body burden as measured by blood Pb levels. When back~- ground Pb levels, as reflected by blood Pb measurements for that geographic area are significantly exceeded, the woman should be advised to consider other work assign- ments that would not expose her to Pb or its compounds. For other workers, while no one piece of evidence suggests significant health effects following exposure to Pb resulting in blood Pb levels of 50 micrograms per deciliter (ug/dL), the data taken together suggest a prudent practice to have a program to reduce blood Pb levels to 35 ug/dbL or below. NOTES ON EXPOSURE LIMITS: PELs

Potential health effects

of overexposure may include: BY SKIN OR EYE CONTACT: Skin irritation with discomfort or rash; Allergic skin rashes; Eye irritation with discomfort, tearing, or blurring of vision; Infrequently associated with skin sensitization in humans; BY INHALATION: Irritation of the upper respiratory passages; BY INGESTION: Gastrointestinal tract irritation with upper abdominal pain (heartburn), nausea, vomiting and diarrhea; possibly "coffee grounds" vomitus and black, tarry stools from gastrointestinal bleeding; BY INHALATION OR INGESTION: Nonspecific discomfort, e.g., nausea, headache or weakness; Diarrhea. ****Human effects of higher level acute, repeated or chronic overexposure may include: BY INGESTION: Temporary nervous system depression with anaesthetic effects such as dizziness, headache, confusion, incoordination, loss of consciousness and possibly respiratory failure. ***In addition: BY INGESTION: Small amounts of this ingredient aspirated into the lungs during ingestion or vomiting may cause chemical pneumonia. Symptoms include coughing, gasping, choking, shortness of breath, bluish skin coloration, fever, rapid heart rate and breathing. Symptoms may be delayed up to 24 hours. >>>Diethylene Glycol Dibutyl Ether ****Toxic effects described in animals include: BY SKIN CONTACT: Slight skin irritation; BY EYE CONTACT: Slight eye irritation. ****Additional animal tests have shown: No animal test reports are available to define carcinogenic, mutagenic, embrytoxic or reproductive hazards, of overexposure may include: BY SKIN CONTACT: May irritate skin; May be absorbed through skin; BY EYE CONTACT: May cause irritation; Burning sensation; BY INHALATION: Irritation of the nose and throat; Irritation of lungs; BY INGESTION: Irritation of gastrointestinal tract; Irritation of mouth; Irritation of the nose and throat. ***In addition: No known effects of overexposure, however, compounds of the group "glycol diethers" with similar chemical structure, in studies involving laboratory animals, have shown to cause reversible testicular and sperm damage as well as birth defects. >>>Modified Epichliorohydrin Resin *xk**Toxic effects described in animals include: BY SKIN OR EYE CONTACT: Skin irritation; Eye irritation. ****Additional animal tests have shown: Carcinogenic toxicity; Genetic damage in animals, bacterial or mammalian cell cultures. of overexposure may include: BY SKIN OR EYE CONTACT: Skin irritation with discomfort or rash; Eye irritation with discomfort, tearing, or blurring of vision. (CONTINUED) 0001 PAGE 3 of overexposure may include: BY SKIN CONTACT: May cause irritation; BY EYE CONTACT: May cause irritation; Photophobia; BY CONTACT, INHALATION, OR INGESTION: Argyria, a blue-gray discoloration of the skin, Mucous membranes, inner surface of eyelids, cornea or lens. ***In addition: There is no effective treatment for argyria. Cases of argyria have not resulted from exposure to silver concentrations in air of less than 0.01 mg/m3; Inhalation of fumes of this metal may cause metal fume fever. >>>Ruthenium Dioxide **e*Toxic effects described in animals include: BY CONTACT, INHALATION, OR INGESTION: Lung effects. of overexposure may include: BY SKIN CONTACT: May cause dermatitis; BY CONTACT, INHALATION, OR INGESTION: Allergic skin rashes; Irritation of the upper respiratory passages. >>>Palladium (Metallic) xe**Toxic effects described in animals include: BY SKIN CONTACT: Skin irritation; No skin sensitization; BY EYE CONTACT: Not an irritant. ****Additional animal tests have shown: No reproductive toxicity; Tests in animals demonstrate no embryotoxic activity; No animal data available to define mutagenicity; No animal data available to define carcinogenicity. of overexposure may include: BY SKIN OR EYE CONTACT: Skin irritation with discomfort or rash; Bye irritation with discomfort, tearing, or blurring of vision; BY SKIN CONTACT: May cause irritation; BY EYE CONTACT: May cause irritation; BY INHALATION: May cause respiratory tract irritation; BY INGESTION: May be harmful, ****Human effects of higher level acute, repeated or chronic overexposure may include: BY SKIN CONTACT: May cause sensitization. ***In addition: In laboratory tests, palladium appears to bind to many cell components; blocks the action of a number of enzymes and interferes with the use of energy by nerves and muscles; induces lung malfunction and produces abnormal fetuses. Lethal intravenous doses cause loss of appetite, blood effects, kidney effects and bone marrow ffonts £ 8. >>eOlefinic Polymer ****Toxic effects described in animals include: BY SKIN OR EYE CONTACT: No skin irritation. Toxic effects of repeated or prolonged animal exposures include: No toxic effects; (CONTINUED) 0001 of overexposure may include: BY SKIN OR EYE CONTACT: Eye irritation with discomfort, tearing, or blurring of vision. >>e>Ethyl Cellulose **k**Toxic effects described in animals include: Skin irritation; BY INGESTION: No toxic effects. of overexposure may include: BY SKIN CONTACT: May cause mild irritation; BY EYE CONTACT: Nuisance particulate may cause eye irritation; BY INHALATION: Dust may cause irritation to upper respiratory tract. >e>Fatty Acid Derivative ****Toxic effects described in animals include: Skin irritation; Eye irritation; No toxic effects. >>eAlkyl Phenolic Resin of overexposure may include: BY SKIN CONTACT: Dermatitis; Allergic skin rashes; BY EYE CONTACT: May cause conjunctivitis; May cause mechanical eye irritation; May cause irritation. ****Human effects of higher level acute, repeated or chronic overexposure may include: May affect liver and kidneys; Irregular heartbeat. ***In addition: Formaldehyde may be liberated from the resin at elevated temperatures, for example, during a curing process. Based on non-human laboratory testing, formaldehyde has shown mutagenic and carcinogenic toxicity. of overexposure to Formaldehyde vapors may include: SKIN ixritation with discomfort or rash; EYE irritation with discomfort, tearing, blurring of vision; possible eye corrosion with corneal or conjunctival ulceration; INHALATION: Eye irritation with discomfort, tearing or blurring of vision; Nonspecific discomfort, e.g., nausea, headache or weakness; Irritation of upper respiratory passages. Human effects of higher level acute, repeated or chronic overexposure to Formaldehyde vapors may include: SKIN burns or ulcerations; sensitization in susceptible humans. INHALATION: Asthma-like reactions with shortness of breath, wheezing or cough and possibly occuring on subsequent Formaldehyde re-exposure to concentrations below established exposure limits. Over 30 epidemiology studies have been conducted evaluating the possible association between formaldehyde exposure and human cancer. An independent international panel of scientists has reviewed these studies and has concluded that there is no convincing evidence for a relationship between formaldehyde exposure and any specific type of human cancer. yeeCastor oil, dehydrated of overexposure may include: BY SKIN OR EYE CONTACT: May cause irritation. >>>Organic Phosphate of overexposure may include: No acceptable information to confidently predict effects of excessive human exposure; BY SKIN CONTACT: Inflammation; Severe irritation; Blistering; Redness; BY EYE CONTACT: Tearing; Severe irritation; Redness; BY INHALATION: May cause shortness of breath; May cause respiratory tract irritation; (CONTINUED) 0001 PAGE 5 HEALTH HAZARD INFORMATION conrtinuep) Harmful; BY INGESTION: May cause burns to mouth and esophagus; BY CONTACT, INHALATION, OR INGESTION: No information found. Glass or Ceramic ingredient(s) composed of compounds of: >>>Aluminum Toxic effects of chronic animal tests include: BY INHALATION: Pulmonary fibrosis; ****Additional animal tests have shown: No genetic damage in bacterial cell cultures. of overexposure may include: BY SKIN OR EYE CONTACT: Skin irritation with discomfort or rash; BY INHALATION: Temporary lung irritation effects with cough, discomfort, difficulty breathing or shortness of breath. ****Human effects of higher level acute, repeated or chronic overexposure may include: BY INHALATION: Chronic lung disorders with symptoms of lung insufficiency. ***In addition: An epidemiologic study of production workers exposed to this aluminum compound demonstrated no significant increase in the incidence of pulmonary fibrosis or pneumoconiosis; however, a slight decrease in lung function was identified. >>>Aluminum ****Toxic effects described in animals include: BY INGESTION; Reduced growth rate; Bone effects. Toxic effects of repeated or prolonged animal exposures include: BY INHALATION: Accumulation of the compound in body organs; >>>Boron ****Toxic effects described in animals include: BY INGESTION: Testicular effects. Toxic effects of repeated or prolonged animal exposures include: BY INGESTION: Changes in male reproductive organs; Testicular effects; ****Additional animal tests have shown: Reproductive toxicity; No mutagenic toxicity in bacterial or mammalian cell cultures; No carcinogenic toxicity; Developmental effects only at levels producing other toxic effects in adult animal. of overexposure may include: BY SKIN OR EYE CONTACT: Dermatitis; Eye irritation with discomfort, tearing, or blurring of vision; Skin irritation with discomfort or rash; BY INHALATION: Sore throat; Runny nose; Sneezing; Irritation of the nose and throat; BY INGESTION: Irritation of gastrointestinal tract; Heartburn; Stomach pain; Nausea; Vomiting; Diarrhea; BY INHALATION OR INGESTION: Altered kidney function which may be accompanied by abnormal urine volume, low back pain, discomfort or edema; Lethargy; Convulsions; Abdominal cramps; Muscle twitching; Vomiting; Redness of skin; Abnormal liver function with jaundice; Fever. ****Human effects of higher level acute, repeated or chronic overexposure may include: BY SKIN OR EYE CONTACT: Skin reddening; Itching; Burning; Rash; Swelling; Irritation; BY INGESTION: Heartburn; Nausea; Gastrointestinal irritation; Diarrhea; Vomiting; Stomach pain; BY INHALATION OR INGESTION: Skin reddening; Hair loss; Red blood cell destruction; Convulsions; Weight loss; Anemia; Fatality can result from gross overexposure. ***In addition: BY SKIN OR EYE CONTACT: This compound may cause skin sensitization in acrylate- (CONTINUED) 0001 PAGE 6 HEALTH HAZARD INFORMATION continueD) sensitive individuals. >>eCalcium ***e*Additional animal tests have shown: No developmental toxicity; No genetic damage in bacterial cell cultures; No animal data available to define carcinogenicity; No animal data available to define reproductive toxicity. of overexposure may include: BY SKIN CONTACT: May cause skin burns or ulcerations; BY EYE CONTACT: May cause eye corrosion with corneal or conjunctival ulceration; BY INHALATION: Irritation of the upper respiratory passages; Possible perforation of nasal septum; BY INGESTION: Corrosion ef mucosal surfaces; Irritation of mucous membranes. ***In addition: Significant skin permeation appears unlikely; BY SKIN CONTACT: There are no reports on human sensitization. >>>Manganese compounds of overexposure may include: BY CONTACT, INHALATION, OR INGESTION: Skin irritation with discomfort or rash; Eye irritation with discomfort, tearing, or blurring of vision; Nonspecific discomfort, e.g., nausea, headache or weakness. ****Human effects of higher level acute, repeated or chronic overexposure may include: BY CONTACT, INHALATION, OR INGESTION: Nonprogressive but persistent neurologic effects on muscle activity like those sometimes seen in Parkinson’s Disease; Temporary lung irritation effects with cough, discomfort, difficulty breathing or shortness of breath. >preZince ****Toxic effects described in animals include: BY SKIN OR EYE CONTACT: Mild eye irritation; BY INHALATION: Blood effects; Lung effects. Toxic effects of repeated or prolonged animal exposures include: BY INHALATION: Lung effects; Kidney effects; Pancreas effects; ****Additional animal tests have shown: Developmental toxicity; Genetic damage in animals. of overexposure may include: BY SKIN OR EYE CONTACT: Eye irritation with discomfort, tearing, or blurring of vision; BY INHALATION: Irritation of the upper respiratory passages. ***In addition: BY INHALATION: Metal fumes or fine dust may cause metal fume fever with metallic taste, flu-like symptoms, chills, fever, joint and muscle aches, asthma-~like reactions with shortness of breath, wheezing and coughing. Recovery is generally complete within 48 hours. >>>Zirconium ****Toxic effects described in animals include: BY INHALATION OR INGESTION: No toxic effects; No toxic effects. of overexposure may include: BY SKIN OR EYE CONTACT: Skin irritation with discomfort or rash; Bye irritation with discomfort, tearing, or blurring of vision; BY INHALATION: Irritation of the upper respiratory passages with coughing and discomfort. ***In addition: BY SKIN OR EYE CONTACT: There are inconclusive or unverified reports of human sensitization. >>>Barium ****Toxic effects described in animals include: Untested for (CONTINUED) 0001 PAGE 7 HEALTH HAZARD INFORMATION (continued) animal sensitization; BY SKIN CONTACT: Untested for skin irritation; BY EYE CONTACT: Untested for eye irritation. *+*e*AAditional animal tests have shown: No animal test reports are available to define carcinogenic, mutagenic, embrytoxic or reproductive hazards, of overexposure may include: BY SKIN CONTACT: May cause skin burns or ulcerations; BY EYE CONTACT: May cause eye corrosion with corneal or conjunctival ulceration; BY INHALATION: Irritation of the upper respiratory passages; Temporary lung irritation effects with cough, discomfort, difficulty breathing or shortness of breath; BY INGESTION: Gastrointestinal irritation. >e>Silica (Amorphous) ****Toxic effects described in animals include: BY SKIN OR EYE CONTACT: Slight skin irritation; Slight eye irritation; No skin sensitization; BY INGESTION: No toxic effects. Toxic effects of chronic animal tests include: BY INHALATION: Vascular effects; Pulmonary effects; Emphysema; x***Additional animal tests have shown: No carcinogenic toxicity; No reproductive toxicity. of overexposure may include: BY SKIN OR EYE CONTACT: Eye irritation with discomfort, tearing, or blurring of vision; BY INHALATION: Temporary lung irritation effects with cough, discomfort, difficulty breathing or shortness of breath. 4**In addition: Long term overexposure may cause pulmonary inflammation and chronic lung disease based on animal data. >>>Fused Silica (Amorphous) *x***Toxic effects described in animals include: BY SKIN OR EYE CONTACT: Slight skin irritation; Mild eye irritation; No toxic effects; BY INHALATION: Pulmonary fibrosis; Emphysema; Lung effects. ****Additional animal tests have shown: No carcinogenic toxicity; No mutagenic toxicity. ****Human heaith effects of overexposure may include: BY SKIN OR EYE CONTACT: Eye irritation with discomfort, tearing, or blurring of vision; BY INHALATION: Temporary lung irritation effects with cough, discomfort, difficulty breathing or shortness of breath. ***In addition: Significant skin permeation appears unlikely; Epidemiologic studies show no significant risk of human cancer from exposure to this component. >>>Lead x*ee4DGditional animal tests have shown: [** NOTE: The health effects data described herein are for the substance "lead monoxide". Where relevant, additional data on related "lead" and "lead compounds" are also provided.** ]. == No animal tests are available on lead monoxide for carcinogenicity, mutagenicity, developmental, or reproductive toxicity. However, some lead compounds have produced kidney tumors in animals following long term, high-level exposure. == Tests in animals indicate that lead compounds may have developmental toxicity. Lead has caused developmental delays, neurobehavioral abnormalities in offspring of animals exposed during pregnancy, which suggests that the fetus may be more sensitive to the effects of lead than the maternal animals. However, lead compounds do not appear to cause malformations. == Tests in animals indicate that lead compounds may have reproductive toxicity. == Lead monoxide does not produce (CONTINUED) 0001 PAGE 8 HEALTH HAZARD INFORMATION (contiNUED) genetic damage in bacterial or mammalian cell cultures but does produce damage in human lymphocytes. Lead monoxide has not been tested for heritable genetic damage. of overexposure may include: BY SKIN CONTACT: Skin permeation can occur in amounts capable of producing effects of systemic toxicity; There are no reports of human sensitization; BY EYE CONTACT: Eye irritation with discomfort, tearing, or blurring of vision. ****Human effects of higher level acute, repeated or chronic overexposure may include: BY INHALATION OR INGESTION: ++ Early responses to lead overexposure include abnormal functioning of the blood forming system, or red blood cell destruction that may progress to anemia. == Early overt symptoms of lead overexposure may include fatigue, nervousness, anxiety, sleeplessness, mood changes, headache. == Higher lead exposures may cause tremors, hallucinations, which can progress to delerium, mania, convulsions, paralysis, coma and death. == Lead overexposure may also cause: abnormal kidney function as detected by laboratory tests, reduced urine volume or edema, elevation of blood pressure, cardiovascular changes such as abnormalities in the heart‘s electrical activity, irregular heartbeats; nervous system damage with effects such as muscular weakness, palsy, incoordination; suppression of the immune system with increased susceptibility to disease; gastrointestinal disturbances with loss of appetite, upset stomach, diarrhea, constipation, and sometimes colic. == Long-term exposure may cause kidney disease, kidney failure. ***In addition: ++ DuPont considers lead and its compounds to be PROBABLE HUMAN REPRODUCTIVE TOXINS. Impairment of the male reproductive function (prostate and testes) may occur with effects such as reductions in sperm count, volume and density, and by changes in sperm motility and morphology. == Epidemiology studies reported in the literature suggest an association between high blood lead levels in some lead workers and increased blood presssure, ECG abnormalities, increases in colo-rectal cancer, and increased chronic kidney disease. >>rLead *x***Additional animal tests have shown: [** NOTE: The health effects data described herein are for the substance "lead tetraoxide". Where relevant, additional data on related "lead" and "lead compounds" are also provided.** ]. | Lead tetraoxide is untested for skin or eye irritancy, and is untested for animal sensitization. No animal tests are available on lead tetraoxide for carcinogenicity, mutagenicity, developmental, or reproductive toxicity. However, some lead compounds have produced kidney tumors in animals following long term, high-level exposure. _ Tests i of overexposure may include: BY SKIN CONTACT: Skin irritation with discomfort or rash; Significant skin permeation appears unlikely; There are no reports of human sensitization; BY EYE CONTACT: Eye irritation with discomfort, tearing, or blurring of vision. ****Human effects of higher level acute, repeated or chronic overexposure may include: BY INHALATION OR INGESTION: ++ Early responses to lead overexposure include abnormal functioning of the blood forming system, or red blood cell destruction that may progress to anemia. == Early overt symptoms of lead (CONTINUED o00t PAGE 9 HEALTH HAZARD INFORMATION (continued) overexposure may include fatigue, nervousness, anxiety, sleeplessness, mood changes, headache. == Higher lead exposures may cause tremors, hallucinations, which can progress to delerium, mania, convulsions, paralysis, coma and death. == Lead overexposure may also cause: abnormal kidney function as detected by laboratory tests, reduced urine volume or edema, elevation of blood pressure, cardiovascular changes such as abnormalities in the heart’s electrical activity, irregular heartbeats; nervous system damage with effects such as muscular weakness, palsy, incoordination; suppression of the immune system with increased susceptibility to disease; gastrointestinal disturbances with loss of appetite, upset stomach, diarrhea, constipation, and sometimes colic. == Long-term exposure may cause kidney disease, kidney failure, ***In addition: ++ DuPont considers lead and its compounds to be PROBABLE HUMAN REPRODUCTIVE TOXINS. Impairment of the male reproductive function (prostate and testes) may occur with effects such as reductions in sperm count, volume and density, and by changes in sperm motility and morphology. == Epidemiology studies reported in the literature suggest an association between high blood lead levels in some lead workers and increased blood presssure, ECG abnormalities, increases in colo-rectal cancer, and increased chronic kidney disease. >>>Strontium of overexposure may include: No information found. Individuals may have increased susceptibility to

SECTION 2: Hazards identification

of overexposure to ingredient(s) of this product if they have pre- { existing diseases of the: Skin; Central nervous system; Eyes; Respiratory system; Cardiovascular system; Blood; Liver; Gastrointestinal tract; Lungs; Kidneys. ANIMAL DATA: >>>Terpineol (Mixed Isomers) Inhalation (Aerosol) 4 hours [Rats]: 3.70 mg/l Oral LDSO [Rat]: >2.0 g/kg Skin LD50 [Rabbit]: >2.0 g/kg. >>>Diethylene Glycol Dibutyl Ether Oral LDSO [Rats]: 3,900 mg/kg Skin absorption LD50 [Rabbits]: 5,040 mg/kg. >>>Modified Epichlorohydrin Resin Oral LD50 [Rats]: 11,400 mg/kg Skin Absorption LD50 [Rabbits]: 20 mL/kg. paaSilver (Metallic) Oral LD50 [Mice]: 210 g/kg. >>>Ruthenium Dioxide Oral LDSO [Rats]: 4,580 mg/kg. >>>Palladium (Metallic) (CONTINUED 0001 PAGE 10 HEALTH HAZARD INFORMATION contiNuED) Inhalation 1 hr LCS5O [Rats]: 0.041 mg/L Oral LD50 [Rats]: 200 mg/kg. >>>Olefinic Polymer Oral LD 50 [Rats]: > 2,500 mg/kg. >>>Ethyl Cellulose ORAL LDS50 [Rats]: »5000 mg/kg Skin Absorption LD50 [Rabbits]: >5000 mg/kg. >>>Fatty Acid Derivative No information found. >>>Alkyl Phenolic Resin No information found. >eeCastor oil, dehydrated No information found. >e>Organic Phosphate Eye (Rabbit): Severe Irritation Skin (Rabbit): Severe Irritation Oral LDS5O (Rat): 4450 mg/kg. Glass or Ceramic ingredient (s) composed of compounds of: >>>Aluminum Oral LDSO [Rats]: >25,000 mg/kg. >>>Aluminum Oral ALD [Rats]: >11,000 mg/kg. >>>Boron Oral LD50 [Rats]: 3,450 mg/kg. >>>Calcium No information found. >peZine Inhalation LD50: 2500 mg/m3 in mice Oral LD50: 7950 mg/kg in mice. >>>Zirconium No information found. >>>Barium No information found. >>>Silica (Amorphous) Oral LD50 [Rats]: > 10,000 mg/kg. >>>Fused Silica (Amorphous) Inhalation 6 hour LCSO [Rats]: >250 mg/m3 Oral LD50 [Rats]: >7,500 mg/kg. p>eLead Inhalation 1 hr LCSO [Rats]: no deaths at 3.72 mg/L exposure Oral LDSO [Rats]: >25,000 mg/kg. (CONTINUED) 0001 PAGE 14 HEALTH HAZARD INFORMATION continuep) >>>Lead No information found. CARCINOGENICITY LISTING: The following ingredients are listed as potential carcinogens: INGREDIENT ACGIH

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.